You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 143 No. 7, July 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Neurofibromatosis type 1 (Recklinghausen's disease). Neurologic and cognitive assessment with sibling controls

R. Eldridge, M. B. Denckla, E. Bien, S. Myers, M. I. Kaiser-Kupfer, A. Pikus, S. L. Schlesinger, D. M. Parry, J. M. Dambrosia, M. A. Zasloff and al. et
Neuroepidemiology Branch National Institutes of Health, Bethseda, Md.

Neurologic and cognitive function in neurofibromatosis type 1 (NF1) were assessed in a controlled pilot study of 13 pairs of siblings aged 6 to 27 years. One subject in each pair was affected with NF1, and the other, the control subject, was unaffected. Subjects with evidence of focal central nervous system disease were excluded. The 13 subjects with NF1 had no excess of mental retardation, attention-deficit disorder, or specific learning disorders (using Wilcoxon's Signed Rank Test and McNemar's Test for Symmetry). These subjects, however, had significantly higher scores for subtle neurologic abnormalities (21 vs 6) and significantly lower full-scale IQ scores (94 vs 105) than their unaffected siblings. The IQ scores of the affected subjects were not clustered at the lower end of the scale but showed a slight downward shift in distribution compared with those of their siblings. In addition, a visual-spatial orientation deficit was present in eight of nine affected subjects so evaluated. The findings suggest that subjects with NF1 have a widespread alteration of the brain during development that manifests as one or more specific types of neuropsychologic deficits.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Health Supervision for Children With Neurofibromatosis
Hersh and Committee on Genetics
Pediatrics 2008;121:633-642.
ABSTRACT | FULL TEXT  

Neurofibromatosis type 1: Motor and cognitive function and T2-weighted MRI hyperintensities
Feldmann et al.
Neurology 2003;61:1725-1728.
ABSTRACT | FULL TEXT  

Ocular Motor Behavior of Children With Neurofibromatosis 1
Lasker et al.
J Child Neurol 2003;18:348-355.
ABSTRACT  

A child with axillary freckling and cafe au lait spots
Wainer
CMAJ 2002;167:282-283.
FULL TEXT  

Review Article : Cognitive Deficits in Neurofibromatosis 1
North et al.
J Child Neurol 2002;17:605-612.
ABSTRACT  

Review Article : Molecular and Cellular Mechanisms Underlying the Cognitive Deficits Associated With Neurofibromatosis 1
Costa and Silva
J Child Neurol 2002;17:622-626.
ABSTRACT  

Prospective Evaluation of the Brain in Asymptomatic Children with Neurofibromatosis Type 1: Relationship of Macrocephaly to T1 Relaxation Changes and Structural Brain Abnormalities
Steen et al.
Am. J. Neuroradiol. 2001;22:810-817.
ABSTRACT | FULL TEXT  

Brain volume in children with neurofibromatosis type 1: Relation to neuropsychological status
Moore et al.
Neurology 2000;54:914-920.
ABSTRACT | FULL TEXT  

Brain tumors in children with neurofibromatosis: Additional neuropsychological morbidity?
De Winter et al.
Neuro Oncol 1999;1:275-281.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.